The platelet IIb/IIIa inhibitor abciximab as adjunctive therapy in carotid stenting of potential thrombotic lesions

Journal of Interventional Cardiology

Volumn 12, Issue 5, 1999, Pages 355-361

  Ceceña, Felipe A ^a   Hoelzinger, David H ^a   Miller, Jess A ^a   Abu Shakra, Sawsan ^a  

^a Arizona Heart Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CAROTID ARTERY OBSTRUCTION; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MALE; PRIORITY JOURNAL; STROKE; TREATMENT OUTCOME;

EID: 0032716904     PISSN: 08964327     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8183.1999.tb00259.x     Document Type: Article

References (22)

1. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445-453.
2. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273:1421-1428.
3. Tsai FY, Matovich V, Hieschima G, et al. Percutaneous transluminal angioplasty of the carotid artery. Am J Neuroradiol 1986;7:349-358.
4. Kachel R, Basche S, Heerklotz I, et al. Percutaneous transluminal angioplasty of supra-aortic stenosis, especially the internal carotid artery. Neuroradiology 1991;33:191-194.
5. Theron J, Raymond J, Casaco A, et al. Percutaneous angioplasty of atherosclerotic and postsurgical stenosis of carotid arteries. Am J Neuroradiol 1987;8:495-500.
6. Yadav JS, Roubin GS, Iyer S, et al. Elective stenting of the extracranial carotid arteries. Circulation 1997;95:376-381.
7. Yadav JS, Roubin GS, King P, et al. Angioplasty and stenting for restenosis after carotid endarterectomy. Initial experience. Stroke 1996;27:2075-2079.
8. Wholey MH, Wholey M, Bergeron P, et al. Current global status of carotid artery stent placement. Cathet Cardiovasc Diagn 1998;44:1-6.
9. Theron JG, Payelle GG, Coskun O, et al. Carotid artery stenosis: Treatment with protected balloon angioplasty and stent placement. Radiology 1996;201:627-636.
10. Fuster V, Jang I-K. Role of platelet-inhibitor agents in coronary artery disease. In: Topol EJ, ed. Textbook of Interventional Cardiology. Philadelphia: WB Saunders, 1994, pp. 3-22.
11. The EPISTENT Investigators. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet 1998;352:87-92.
12. Kereiakes DJ, Lincoff AM, Miller DP, et al. Abciximab therapy and unplanned coronary stent deployment: Favorable effects on stent use, clinical outcomes, and bleeding complications. Circulation 1998;97:857-864.
13. Zidar JP, Kruse KR, Thel MC, et al. Integrilin for emergency coronary stenting. (abstract) J Am Coll Cardiol 1996;37:138A.
14. Brott T, Adams HP Jr, Olinger CP, et al. Measurements of acute cerebral infarctions: A clinical examination scale. Stroke 1989;20:864-870.
15. Sundt TM Jr, Whisnant JP, Houser OW, et al. Prospective study of the effectiveness and durability of carotid endarterectomy. Mayo Clin Proc 1990;65:625-636.
16. Ohki T, Marin ML, Lyon RT, et al. Development of a human model for ex vivo carotid angioplasty and stenting. J Endovasc Surg 1997;4(Suppl 1):I30-I31.
17. Mathur A, Roubin GS, Iyer SS, et al. Predictors of stroke complicating carotid artery stenting. Circulation 1998;97: 1239-1245.
18. AbuRahama AF, Covelli MA, Holt SM. The role of carotid duplex ultrasound in evaluating plaque morphology: Potential use in selecting patients for carotid stenting. J Endovasc Surg 1998;5(Suppl I):I-1.
19. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high risk angioplasty. N Engl J Med 1994;330:956-961.
20. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997;336:1689-1696.
21. The CAPTURE Investigators. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE study. Lancet 1997;349:1429-1435.
22. Jordan RE, Mascelli MA, Nakada MT, et al. Pharmacology and clinical development of abciximab (c7E3 Fab, ReoPro); A monoclonal antibody inhibitor of GPIIb/IIIa and v3. In: Sasahara AA, Loscalzo J, eds. New Therapeutic Agents in Thrombosis and Thrombolysis. New York: Marcel Dekker, Inc., 1997, pp. 291-332.